Thomas W. Dubensky - 21 Jun 2022 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
President, Director
Signature
/s/ Pierre Lorenzo, Attorney-in-Fact for Thomas W. Dubensky
Issuer symbol
TPST
Transactions as of
21 Jun 2022
Transactions value $
$0
Form type
4
Filing time
22 Jun 2022, 16:31:29 UTC
Previous filing
11 Jan 2022
Next filing
19 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Stock Option (Right to Buy) Award $0 +87,801 $0.000000 87,801 21 Jun 2022 Common Stock 87,801 $2.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests over four (4) years, with one-fourth (1/4) of the award vesting on the first anniversary of the date of grant and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.